Thyroid medicine recall receives FDA's highest risk level - USA Today

As reported by USA Today

A recalled thyroid medicine has been classified under the FDA's most serious risk level, indicating it could potentially be deadly.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on USA Today ↗

Market Samachar is a news aggregator. This article was originally published by USA Today. Tap the button above to read the full story on their site.

INDIAN SIDBI withdraws ₹6,000 crore three-year bond issue as yields harden Share Market Today
INDIAN Steel Authority of India and Bharat Coking Coal signs MoU Share Market Today
INDIAN One 97 Communications hikes stake in its subsidiary - Little Internet Share Market Today
INDIAN Lumax Auto Technologies announces change in senior management Share Market Today
INDIAN PC Jeweller achieves debt-free status Share Market Today
INDIAN Edelweiss concludes sale of 45% stake in Nido Home Finance Share Market Today
INDIAN PB Fintech's 2-day fall costs mutual fund investors nearly ₹11,000 crore Share Market Today
INDIAN PVR Inox opens 5-screen multiplex at MyMoon, Kochi Share Market Today

Thyroid medicine recall receives FDA's highest risk level - USA Today

More from Market Samachar